AnaptysBio, Inc.

NASDAQ:ANAB

Biotechnology

Healthcare
$47.40 -1.88%

-$1.07 today

Market cap
$1.41B
Beta
0.41
P/E (TTM)
-59.7
EPS (TTM)
-$0.93
52W Low $11.40High $72.36

Volume 0.51M

Average 0.76M

Balance Sheet

Inspect the capital base behind the business.

Assets

$364.39M

FY 2025 · Annual

-24.7% YoY

Liabilities

$327.19M

FY 2025 · Annual

-20.8% YoY

Equity

$37.21M

FY 2025 · Annual

-47.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents495.73M71.31M35.97M123.08M238.2M
Short-term Investments52.37M369.93M354.94M262.29M73.44M
Net Receivables876K1.42M6.85M40.77M33.85M
Inventory00000
Other Current Assets04.55M9.08M5.74M4.76M
Total Current Assets553.88M447.21M406.84M431.88M350.25M
Property, Plant & Equipment (Net)21.84M19.99M18.27M16.23M13.89M
Goodwill00000
Intangible Assets00000
Long-term Investments67.1M142.94M27.03M35.47M0
Tax Assets00000
Other Non-current Assets256K256K256K256K256K
Total Non-current Assets89.19M163.18M45.55M51.96M14.15M
Total Assets643.07M610.38M452.39M483.83M364.4M
Account Payables1.74M2.78M4.7M4M3.87M
Short-term Debt0001.93M0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities4.18M5.38M23.77M31.05M11.09M
Total Current Liabilities16.1M26.05M37.44M45.43M38.63M
Long-term Debt000353.43M12.03M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities251.09M304.41M310.81M0276.53M
Total Non-current Liabilities270.54M322.23M326.84M367.54M288.56M
Total Liabilities286.64M348.28M364.29M412.97M327.19M
Common Stock28K29K27K30K28K
Retained Earnings(321.75M)(450.48M)(614.1M)(759.33M)(772.56M)
Accumulated OCI(422K)(5.25M)(797K)305K(24K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity356.43M262.1M88.1M70.87M37.21M
Total Debt20.96M19.45M17.81M369.46M14.11M
Net Debt(474.77M)(51.86M)(18.15M)246.38M(224.08M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$248.5M
Short-term Investments$38.0M
Receivables$25.7M
Other Current$3.9M
Total Current Assets$316.1M
PP&E (Net)$13.3M
Other Non-current$256.0K
Total Non-current Assets$13.6M
Total Assets$329.7M

Analysis

Selected assets total $329.7M for Latest. The largest visible component is Cash & Equivalents at $248.5M, about 75.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipOct 2, 2026
10-KT10-KT filingSep 21, 2026
8-KCurrent reportSep 21, 2026

How much cash does ANAB have?

AnaptysBio, Inc. (ANAB) reported $238.20M in cash and equivalents in fiscal 2025.

How much debt does ANAB carry?

AnaptysBio, Inc. (ANAB) reported $14.11M of total debt, with net debt of -$224.08M.